Alembic Pharmaceuticals Limited has informed the Exchange about change in Management
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alembic Pharmaceuticals has informed the stock exchanges that four senior executives — Mr. Ajay Desai (Sr. VP-Finance), Mr. Amresh Choudhary (Head-Legal & Taxation), Mr. Manuj Desai (Head-IT), and Mr. Jigr Shah (Head-Business Finance) — will cease to be designated as Senior Management Personnel effective 8th July 2025. The change is due to an internal restructuring of reporting lines; these individuals will now report directly to the Chief Financial Officer. None of the four are leaving the company — they are continuing in their roles but losing the SMP classification under SEBI's Listing Regulations. The disclosure was filed under Regulation 30 of the SEBI LODR, 2015.
This is a routine internal administrative restructuring with no change in personnel or business operations. Shareholders are unlikely to see any material impact on the company's financials, strategy, or stock price, as the executives remain with the company in similar roles.